Our client is a pre-clinical stage private company developing peptide-based drugs for patients suffering from Type 2 diabetes which offer a unique treatment option notably for insulin-resistant patients. The company was cofounded by worldwide key opinion leader in the field of metabolic diseases. The organization relies on an experienced team mostly external so far. 15 […]